Caitong International Asset Management Co., LTD Zentalis Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 9 shares of ZNTL stock, worth $11. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9Holding current value
$11% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ZNTL
# of Institutions
140Shares Held
59.1MCall Options Held
7.9KPut Options Held
42.5K-
Matrix Capital Management Company, LP Waltham, MA14MShares$17.6 Million6.94% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$6.07 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$4.11 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.07MShares$3.87 Million0.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC2.1MShares$2.65 Million23.31% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $71.8M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...